Skip Navigation
Skip to contents

J Stroke.  2026 Jan;28(1):46-57. 10.5853/jos.2025.01431.

Endovascular Therapy for Extensive Infarction in Acute Ischemic Stroke

Affiliations
  • 1Department of Neurology and Neurosurgery, Barrow Neurological Institute, Phoenix, AZ, USA
  • 2Universidade Federal de São and Hospital Israelita Albert Einstein, São Paulo, Brazil
  • 3Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China
  • 4Department of Neurology, Aarhus University Hospital, Aarhus, Denmark
  • 5Department of Neurology, Mayo Clinic, Rochester, MN, USA
  • 6Department of Neurology, Neurovascular Imaging Research Core, University of California, Los Angeles, CA, USA

Abstract

Acute ischemic stroke is the leading cause of permanent disability and second leading cause of death worldwide. Over the past 10 years, mechanical thrombectomy has become a powerful technique for improving outcomes after large-vessel occlusion in patients with a small baseline infarct. Reperfusion in patients with extensive infarction has historically been considered futile or harmful. However, a recent series of trials showed that endovascular therapy benefits patients who present with extensive baseline infarction. These new data represent a paradigm shift in the approach to stroke therapy, leading to an expansion of indications. Therefore, more patients will benefit from mechanical thrombectomy. Furthermore, these data challenge current definitions of infarct and ischemia as seen on imaging. The data suggest a new era of reperfusion therapy that focuses on optimizing patient-specific approaches and developing adjunctive neuroprotectants and neurorestorative therapies.

Keyword

Ischemic stroke; Large core; Large vessel occlusion; Precision medicine; Thrombectomy
Full Text Links
  • JOS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2026 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr